Tuberculosis (TB) is a global health problem,
killing 1.5 million of people every year.
The primary outcome of EMI-TB will be a novel vaccine candidate for TB. Continue Reading
The Biomedical Research Centre (Centro de Investigacións Biomédicas), CINBIO, is a multidisciplinary research centre of the University of Vigo that emerged to create a common infrastructure for biomedical experts. Continue Reading
Nanoimmunotech is born from the cooperation of the Immunology group from the Biomedical Research Center (CINBIO) of Vigo and the Nanoscience Institute of Aragón (INA). Continue Reading
Over the years, this research group leaded by Prof. África González Fernández has developed several projects funded by Europe, the Spanish and Galician governments, foundations and also by private enterprises. Continue Reading
Recent publications in Nanotechnology of the Immunology Group Continue Reading
World Tuberculosis Day Continue Reading
NANOeaters Continue Reading
Day of Immunology 2018 Continue Reading
Festival Pint of Science in Vigo Continue Reading
II Annual Meeting CINBIO Continue Reading
Sunday 2 to Wednesday 5 September 2018 Continue Reading
Líneas actuales de investigación
Nanoparticle-based technology has proven to be an extraordinary tool to develop new drug delivery nanosystems and antigen delivery systems. Continue Reading
Tuberculosis is an infectious disease caused by the mycobacteria Mycobacterium tuberculosis and it is one of the top 10 causes of mortality worldwide. Continue Reading
Development of new vaccines.
Design of peptide-based therapeutic nanostructures for the treatment and/or prevention of autoimmune diseases.
Nanovaccines. Continue Reading
